in patients undergoing to activated lymphocytes in patients with A) an organ is transplanted, and B) radiation therapy, as a radiation sensitizer for cancer cells, as a drug carrier in the diagnosis and treatment of C) cancer of vitamin-binding protein in the target-oriented delivery of cytotoxic

摘要

This invention relates to the targeted delivery of cytotoxic drugs: A) to lymphocytes responsible for the rejection of transplanted tissues, such as kidneys or hearts or bone marrow cells; B) the use of a non-toxic naturally existing delivery system to transport high concentrations of radiosensitizers to cancer cells; and C) to the targeted delivery of drugs in medical diagnosis and treatment of cancer.